MICHELLE GULBRANDSON: Open Payments
NPI 1124319082 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478 in 6 payments from 6 companies in 2025. Trend: 2023 $115 · 2024 $442 · 2025 $478
Food & beverage: $383Education: $95
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 1 | $143 |
| Teleflex LLC | 1 | $118 |
| Astellas Pharma US Inc | 1 | $95 |
| GlaxoSmithKline, LLC. | 1 | $53 |
| Novartis Pharmaceuticals Corporation | 1 | $35 |
| Novo Nordisk Inc | 1 | $34 |
Products named: Onivyde, ARROW, BLENREP, Wegovy.
Industry payments across NE — which companies pay providers there.
